MARKET WIRE NEWS

Harrow: The Post Earnings Drop Exposes The Cost Of Growth (Rating Downgrade)

Source: SeekingAlpha

2026-03-04 06:46:19 ET

Overview

My last look at Harrow ( HROW ) was in August 2025. I have been one of the few analysts on the platform who’s expressed caution. But Harrow’s growth is undeniable. Its YoY revenue growth in the past several quarters has been consistently ?30%, and 36% YoY in FY25 compared to FY24. ...

Read the full article on Seeking Alpha

For further details see:

Harrow: The Post Earnings Drop Exposes The Cost Of Growth (Rating Downgrade)
Harrow Health Inc.

NASDAQ: HROW

HROW Trading

6.74% G/L:

$36.57 Last:

416,198 Volume:

$35.15 Open:

mwn-alerts Ad 300

HROW Latest News

HROW Stock Data

$1,766,316,134
31,422,575
N/A
85
N/A
Pharmaceuticals
Healthcare
US
Nashville

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App